Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK)

CUSIP: 035255108

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
14,423,417
Total 13F shares
13,000,312
Share change
-486,354
Total reported value
$375,884,789
Put/Call ratio
291%
Price per share
$28.91
Number of holders
160
Value change
-$23,630,047
Number of buys
72
Number of sells
97

Quarterly Holders Quick Answers

What is CUSIP 035255108?
CUSIP 035255108 identifies ANIK - Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) as of Q1 2020

As of 31 Mar 2020, Anika Therapeutics, Inc. - Common Stock, par value $0.01 per share (ANIK) was held by 160 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,000,312 shares. The largest 10 holders included BlackRock Inc., KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, AMERIPRISE FINANCIAL INC, Boston Trust Walden Corp, WELLS FARGO & COMPANY/MN, and D. E. Shaw & Co., Inc.. This page lists 160 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.